我要投票 德维喜DOVC在其他行业中的票数:579
· 外 推 电 报 ·
2026-01-08 15:28:16 星期四

【德维喜DOVC是哪个国家的品牌?】

德维喜DOVC是什么牌子?「德维喜DOVC」是 东北制药集团股份有限公司 旗下著名品牌。该品牌发源于辽宁省沈阳市,由创始人魏海军在1993-06-10期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力德维喜DOVC品牌出海!将品牌入驻外推网,定制德维喜DOVC品牌推广信息,可以显著提高德维喜DOVC产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

创始于1993年,知名维生素品牌,覆盖医药研发、制造、分销全产业链条,以化学原料药为主的大型综合性制药企业


东北制药集团股份有限公司(简称“东北制药”,股票代码:000597),是辽宁方大集团实业有限公司(简称“方大集团”)旗下上市公司。公司前身为东北制药总厂,始建于1946年,曾援建全国19省市52家医药企业,向外输送干部1300多人。

目前,东北制药拥有化学原料药、化学制剂、医药商业、医药工程、生物医药等主要业务板块,覆盖医药研发、制造、分销全产业链条,员工队伍9300余人,总资产120亿元。公司主要生产维生素系列药品、抗感染系统用药、妇产科系统用药、消化系统用药、泌尿系统用药、抗病毒系列用药、心脑血管系列用药、镇痛镇咳系列用药、生物诊断系列、大健康领域系列等十大系列精品,400多种化学原料药、医药中间体和制剂产品,主导产品远销100多个国家和地区。

公司拥有强大的产品制造体系。制剂生产基地占地18万平方米,拥有生产线30余条,年产能100亿片(支、丸、粒、枚、瓶)。原料药生产基地占地91万平方米,是国家大宗原料药和医药中间体智能制造示范工厂,主要产品包括维生素C及系列、左旋肉碱系列、磷霉素系列、吡拉西坦、卡前列甲酯、金刚烷胺、硫糖铝、黄连素、氯霉素等,并向下游东北制药制剂产业链延伸,形成难以复制的综合竞争优势。

东北制药不仅是中国重要的药品生产与出口基地,还设有药物研究院、工程设计公司、装备制造安装公司、国际贸易公司、计量检测公司、危化品运输公司等各独立业务公司。

东北制药医药商业业务网络覆盖辽宁全部地级市县,并向东北三省延伸,东北大药房拥有百余家连锁店,医药电商业务实现线上线下一体化,商业模式创新持续推进。


英文翻译:Founded in 1993, it is a well-known vitamin brand, covering the whole industrial chain of pharmaceutical research and development, manufacturing and distribution. Northeast Pharmaceutical Group Co., Ltd., a large comprehensive pharmaceutical enterprise mainly engaged in chemical APIs (hereinafter referred to as "Northeast Pharmaceutical", stock code: 000597), is a listed company under Liaoning Fangda Group Industry Co., Ltd. (hereinafter referred to as "Fangda group"). The company, formerly known as the Northeast Pharmaceutical General Factory, was founded in 1946. It has assisted in the construction of 52 pharmaceutical enterprises in 19 provinces and cities across the country, and has sent more than 1300 cadres. At present, Northeast Pharmaceutical has major business sectors such as chemical APIs, chemicals, pharmaceutical commerce, pharmaceutical engineering, biomedicine, covering the whole industrial chain of pharmaceutical research and development, manufacturing, distribution, with more than 9300 employees and a total asset of 12 billion yuan. The company mainly produces ten series of high-quality products, including vitamin series, anti infection system medicine, gynecology and obstetrics system medicine, digestive system medicine, urinary system medicine, anti-virus series medicine, cardiovascular and cerebrovascular series medicine, analgesia and antitussive series medicine, biological diagnosis series, large health field series, more than 400 kinds of chemical APIs, pharmaceutical intermediates and preparation products, leading products It is exported to more than 100 countries and regions. The company has a strong product manufacturing system. The preparation production base covers an area of 180000 square meters, with more than 30 production lines and an annual production capacity of 10 billion tablets (pills, granules, tablets, bottles). The API production base covers an area of 910000 square meters. It is a national bulk API and pharmaceutical intermediate intelligent manufacturing demonstration factory. Its main products include vitamin C and series, L-carnitine series, fosfomycin series, piracetam, carboprost methyl ester, amantadine, sucralfate, berberine, chloramphenicol, etc. and it extends to the downstream Northeast Pharmaceutical industry chain, forming a hard to replicate Comprehensive competitive advantage. Northeast Pharmaceutical is not only an important pharmaceutical production and export base in China, but also has independent business companies such as pharmaceutical research institute, engineering design company, equipment manufacturing and installation company, international trade company, measurement and testing company, dangerous chemicals transportation company, etc. The Northeast Pharmaceutical business network covers all prefecture level cities and counties in Liaoning, and extends to three provinces in Northeast China. The Northeast pharmacy has more than 100 chain stores. The online and offline integration of pharmaceutical e-commerce business is realized, and the innovation of business model is continuously promoted.

本文链接: https://www.waitui.com/brand/aa403ad85.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

蔚来今年将进军澳大利亚和新西兰市场,蔚来将于3月进入泰国市场

据报道,蔚来今年将进军澳大利亚和新西兰市场,蔚来将于3月进入泰国市场。(新浪财经)

2小时前

现货白银向下跌破76美元/盎司

36氪获悉,现货白银向下跌破76美元/盎司,日内下跌2.79%。

2小时前

霸王茶姬回应赴港上市传闻:暂无计划

对于拟赴港二次上市的传闻,霸王茶姬方面回应称,暂无计划。(澎湃)

2小时前

瑞银:外资对中国市场关注度明显回升

瑞银证券董事长胡知鸷透露,将于下周在上海举办的第26届瑞银大中华区研讨会,注册参会客户总数创历史新高,达到3600人,其中投资者约2300人,总体增长11%。值得关注的是,来自美国、欧洲、中东、非洲地区的参会者增长达32%,亚洲以外的全球资金对中国市场的关注度明显回升。外资正从此前相对被动的等待或进进出出的流动状态,转向更主动、长期、有标的可选择的参与交易。(财联社)

2小时前

神经科技品牌LumiMind发布LumiSleep

在CES 2026上,神经科技品牌LumiMind发布首款消费级实时调控脑电睡眠仪LumiSleep。据了解,该产品基于毫秒级脑电监测与闭环神经调控技术,通过实时解析脑电并生成个性化声学引导,帮助大脑自然进入睡眠状态,推动睡眠科技从“被动监测”迈向“主动引导”。其核心技术源自岩思类脑人工智能研究院在脑电解码与脑机接口领域的长期基础研究成果。该产品计划于2026年上半年正式上市,未来会拓展至情绪调节、专注力提升及长期脑健康管理等方向。

2小时前

本页详细列出关于德维喜DOVC的品牌信息,含品牌所属公司介绍,德维喜DOVC所处行业的品牌地位及优势。
咨询